Sort   by:  
 Page size 
UnknownHealth Services Use for SARS-CoV-2-Infected Children With Croup or Bronchiolitis.
Not available
S-EPMC11422672 | biostudies-literature
UnknownPrimary cervical screening with high risk human papillomavirus testing: observational study.
Not available
S-EPMC6364146 | biostudies-literature
UnknownA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Not available
S-EPMC2806600 | biostudies-literature
UnknownIncidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
Not available
S-EPMC6639714 | biostudies-literature
UnknownA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.
Not available
S-EPMC2872173 | biostudies-literature
UnknownResponses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels : A Randomized Controlled Trial.
Not available
S-EPMC9334931 | biostudies-literature
UnknownA Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
Not available
S-EPMC7781100 | biostudies-literature
UnknownRNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.
Not available
S-EPMC10873804 | biostudies-literature
UnknownIntravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial.
Not available
S-EPMC10527239 | biostudies-literature
UnknownEfficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial.
Not available
S-EPMC8700279 | biostudies-literature
Sort   by:  
 Page size